We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+27.62%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$268M
Cap. Flow
+$26.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
33.11%
Holding
117
New
41
Increased
22
Reduced
19
Closed
29

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$17.4M
2
MRK icon
Merck
MRK
+$14.1M
3
NET icon
Cloudflare
NET
+$13.1M
4
FCX icon
Freeport-McMoran
FCX
+$12.9M
5
NVO
Novo Nordisk
NVO
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 32.83%
2 Technology 25.25%
3 Industrials 9.81%
4 Consumer Discretionary 7.9%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWL icon
1
CALL
iShares Russell Top 200 ETF
IWL
$2.16B
$73.6M 7.25%
+3,500
New +$424K
NVDA icon
2
NVIDIA
NVDA
$5.01T
$37.9M 3.74%
420,000
+240,000
+133% +$17.4M
SWAV
3
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$37.3M 3.67%
114,500
+13,000
+13% +$3.19M
MSFT icon
4
Microsoft
MSFT
$2.84T
$36.4M 3.59%
86,500
+16,500
+24% +$6.68M
VRT icon
5
Vertiv
VRT
$112B
$29.3M 2.89%
359,000
-26,000
-7% -$1.63M
INSP icon
6
Inspire Medical Systems
INSP
$1.42B
$27.9M 2.75%
129,735
+8,135
+7% +$1.59M
AMZN icon
7
Amazon
AMZN
$2.5T
$25.1M 2.47%
139,000
+60,000
+76% +$10M
MELI icon
8
Mercado Libre
MELI
$91.3B
$23.4M 2.31%
15,490
-2,000
-11% -$3.27M
LLY icon
9
Eli Lilly
LLY
$1.07T
$23.3M 2.3%
30,000
-1,000
-3% -$712K
ISRG icon
10
Intuitive Surgical
ISRG
$121B
$21.8M 2.15%
54,600
+2,000
+4% +$756K
RXST icon
11
RxSight
RXST
$215M
$21.4M 2.1%
414,000
-30,000
-7% -$1.47M
META icon
12
Meta Platforms (Facebook)
META
$1.51T
$19.9M 1.96%
41,000
-33,000
-45% -$14.7M
S icon
13
SentinelOne
S
$6.22B
$18.6M 1.84%
800,000
+35,000
+5% +$914K
APPF icon
14
AppFolio
APPF
$5.85B
$17M 1.68%
69,000
+8,000
+13% +$1.73M
MLM icon
15
Martin Marietta Materials
MLM
$33.6B
$16.9M 1.66%
27,500
-6,500
-19% -$3.55M
GKOS icon
16
Glaukos
GKOS
$9.02B
$16.5M 1.63%
175,000
+50,032
+40% +$4.47M
BWXT icon
17
BWX Technologies
BWXT
$16B
$15.5M 1.53%
151,000
-14,000
-8% -$1.25M
CNM icon
18
Core & Main
CNM
$8.17B
$15.1M 1.48%
263,000
+63,000
+32% +$2.88M
FCX icon
19
Freeport-McMoran
FCX
$90B
$15M 1.48%
+320,000
New +$12.9M
MRK icon
20
Merck
MRK
$324B
$15M 1.48%
+114,000
New +$14.1M
EXAS
21
DELISTED
Exact Sciences
EXAS
$14.8M 1.46%
215,000
+93,000
+76% +$5.88M
SHW icon
22
Sherwin-Williams
SHW
$78.3B
$14.6M 1.44%
42,000
-15,000
-26% -$4.78M
DXCM icon
23
DexCom
DXCM
$27.6B
$14.3M 1.41%
103,000
MNDY icon
24
monday.com
MNDY
$3.27B
$14.2M 1.4%
63,000
+49,000
+350% +$10.4M
INTC icon
25
Intel
INTC
$466B
$14.1M 1.39%
320,000
+30,000
+10% +$1.34M

Similar funds

Atika Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Atika Capital Management held 117 positions worth $1.02B, up 36% from $747M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atika Capital Management's Q1 2024 filing shows 41 new, 22 increased, 19 reduced and 29 closed positions. Its largest new stake was Merck: 114,000 shares worth $15M. The largest sale was Advanced Micro Devices, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Atika Capital Management's largest Q1 2024 buy was Merck: 114,000 shares worth $15M.
  • Atika Capital Management added most to NVIDIA in Q1 2024, an estimated $17.4M increase.
  • Atika Capital Management's biggest Q1 2024 reduction was Advanced Micro Devices, cutting an estimated $28.8M.
  • Atika Capital Management fully exited Liberty Media Series C in Q1 2024, selling an estimated $13.9M.
  • Atika Capital Management's ten largest holdings make up 33% of its $1.02B portfolio in Q1 2024.
  • Atika Capital Management opened 41 new positions and closed 29 in Q1 2024.
  • Atika Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q1 2024, filed 14 May 2024.